Pfizer Ltd is engaged in manufacturing, marketing, trading and export of pharmaceutical products. It manufactures products through its own facility and also has various independent contract/ third party manufacturers based across the country and sells its products through independent distributors primarily in India. It is the 3rd largest multinational pharmaceutical company in India.
Financial Results:
Pfizer Ltd reported Revenues for Q1FY25 of ₹563.00 Crores up from ₹531.00 Crore year on year, a rise of 6.03%.
Total Expenses for Q1FY25 of ₹402.00 Crores down from ₹440.00 Crores year on year, a fall of 8.64%.
Consolidated Net Profit of ₹151.00 Crores up 60.64% from ₹94.00 Crores in the same quarter of the previous year.
The Earnings per Share is ₹32.94, up 61.15% from ₹20.44 in the same quarter of the previous year.
*It is important to note that the way the results have been accounted for are slightly different than the ones the companies may choose to publish.
*The presented data is automatically generated. It may occasionally generate incorrect information.